Will be part of its Image-Guided Therapy Business Group
Will upgrade to state-of-the-art technology
Funds will include credit monitoring for impacted individuals
Why that is, remains to be understood
A quick look at all the leading modalities in the market
Light-sheet microscope can scan excised breast tissue for cancer cells in 30 minutes
Helps quantify and quickly diagnose conditions
The nuclear medicine world is preparing for the introduction of Ga-68 tracers
Would create a group with at least a 75 percent share of physician services
Shifting from reactive to proactive to reduce breaches
But what about cost-effectiveness?
What to look for when your facility is investing in new systems
Imaging with glucose using 7T MR scanner
Expanding a key manufacturing and R&D facility
Company plans to establish new neurology portfolio
A call to reduce variability in imaging methods used at clinical practices
Automated beds becoming a popular choice
Giving providers more time to adjust to new requirements
Could have implications for stroke victims, Alzheimer's
Says GTC replacement market in 'significant' decline
Mute sequences use software to cut sound by 99 percent
How the son of a notary discovered one of mankind's most troubling neurological diseases
Company aims to attract more U.S. customers
Planned launch in second half of 2017
DoD to invest in over 100 RadPRO1 SOLTUS 100M systems
Henry Ford is installing the MRIdian Linac from ViewRay
'It seems cancer and heart disease coexist in a race to kill cancer survivors'
Workload and time constraints stand in the way
Focusing on one of four ways in which artificial intelligence is disrupting medicine
May reduce unnecessary biopsies
Addressing challenges of reprocessing and reducing HAIs at MD&M East in NYC
Can [F-18] MK-6240 stage neuro-degenerative disease and assess treatment?
Research from Australia presented at SNMMI
Prescient Imaging aims to bring molecular imaging to the patient
How PET and SPECT are reinventing the way we evaluate and image the brain
Swedish researchers take lifesaving cardiac devices to the sky
Findings may have practice-changing implications
Showcasing lower doses, faster scan times and higher sensitivity
Unique market forces influence the utilization of different tracers
Assessing amyloid pathology and neuronal injury in a single session
